Maynard Um
-
-
-
-
-
-
-
Avalo Therapuetics (AVTX) Misses Q1 EPS by 98c
-
-
-
-
-
-
-
Guggenheim on Avalo (AVTX): 'Phase II LOTUS Study Readout in HS Remains On-Track for 2Q26 (Likely in May, Per Our Est)'
-
-
-
-
-
-
-
Avalo Therapeutics Inc. (AVTX) PT Raised to $25 at H.C. Wainwright
-
-
-
-
-
-
-
Avalo Therapuetics (AVTX) Appoints Rita Jain to its Board
-
-
-
-
-
-
-
Piper Sandler Starts Avalo Therapeutics Inc. (AVTX) at Overweight
-
-
-
-
-
-
-
Avalo Therapuetics (AVTX) Misses Q2 EPS by 1407c
-
-
-
422,709 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

